Home > IVD Products > ImmunoAssays > Diabetes & Metabolism > anti-GAD65 > anti-GAD65 RIA, 50 tests

anti-GAD65 RIA, 50 tests

GAD65 autoantibodies are present in 70-80 % of newly diagnosed patients with type 1 diabetes and can be detected many years before clinical onset of the disease. The combination of the autoantibodies to GAD65 and IA2 is highly relevant for risk assessment of type 1 diabetes in children and adolescence. These tests in combination are more sensitive and predictive than ICA in risk groups, e.g. relatives of type 1 diabetes. GAD65 autoantibodies also occur in a subset of adults with type 2 diabetes (non-insulin-dependent diabetes mellitus). These patients can have pronounced hyperglycemia, and after therapy with oral hypoglycemic agents for several months to years they may become insulin dependent. Therefore, these patients are thought to have a slowly progressive form of type 1 diabetes, sometimes called latent diabetes or latent autoimmune diabetes in adults (LADA). The presence of GAD65 autoantibodies in sera of such patients is a sensitive and specific marker for future insulin dependency

Catalog # KIPM2071
Format RIA
Label I125
Size 50 tests
Sample Type Serum
Sample Volume 20 µL
Controls 2 levels
Range 0 - 120 U/ml
Sensitivity 0,7 U/ml
Incubation 120min./60 min./30 min.
Shelf Life (weeks) 5.5

Due to local registration requirement, this product can not be sold in Canada, United States – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: regulatory.affairs@diasource.be.

Documents - Download
Download "Instructions for Use" KIPM2071.pdf
Download "Material Safety Data Sheet" MSKIPM2071.pdf
Download Brochure "Auto-Immunity"
Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.